Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients. | Discov Oncol | 2023 | 38112859 | PubTator, text mining | PubMed |
| Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights. | Biol Methods Protoc | 2023 | 38107402 | PubTator, text mining | PubMed |
| Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study. | Int J Reprod Biomed | 2023 | 38077941 | PubTator, text mining | PubMed |
| Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Infect Med (Beijing) | 2023 | 38076406 | PubTator, text mining | PubMed |
| Contribution of histone variants to aneuploidy: a cancer perspective. | Front Genet | 2023 | 38075697 | PubTator, text mining | PubMed |
| Transcriptomics data mining to uncover signature genes in head and neck squamous cell carcinoma: a bioinformatics analysis and RNA-sequencing based validation. | Am J Cancer Res | 2023 | 38058845 | PubTator, text mining | PubMed |
| An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma. | Heliyon | 2023 | 38053861 | PubTator, text mining | PubMed |
| Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis. | Front Endocrinol (Lausanne) | 2023 | 38053725 | PubTator, text mining | PubMed |
| Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers. | Biomed Res Int | 2023 | 38046902 | PubTator, text mining | PubMed |
| Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival. | Blood Cancer J | 2023 | 38030619 | PubTator, text mining | PubMed |
| Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study. | Front Genet | 2023 | 38028607 | PubTator, text mining | PubMed |
| Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review). | Exp Ther Med | 2023 | 38023367 | PubTator, text mining | PubMed |
| Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients. | Front Oncol | 2023 | 38023151 | PubTator, text mining | PubMed |
| A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells. | Front Oncol | 2023 | 38023136 | PubTator, text mining | PubMed |
| Analysis of Nucleoporin 107 Overexpression and Its Association with Prognosis and Immune Infiltration in Lung Adenocarcinoma by Bioinformatics Methods. | Int J Gen Med | 2023 | 38021066 | PubTator, text mining | PubMed |
| Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets. | Aging (Albany NY) | 2023 | 38019470 | PubTator, text mining | PubMed |
| Dpep Inhibits Cancer Cell Growth and Survival via Shared and Context-Dependent Transcriptome Perturbations. | Cancers (Basel) | 2023 | 38001578 | PubTator, text mining | PubMed |
| Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma. | J Exp Clin Cancer Res | 2023 | 37996944 | PubTator, text mining | PubMed |
| Identification and immune landscape analysis of fatty acid metabolism genes related subtypes of gastric cancer. | Sci Rep | 2023 | 37993654 | PubTator, text mining | PubMed |
| Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 37986299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=12